Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Manganese Steps In For Safer Contrast

Medical Imaging: Alternative to iodine- and gadolinium-based contrast agents is an advantage for patients with kidney problems

by Stephen K. Ritter
December 7, 2015 | A version of this story appeared in Volume 93, Issue 48

Contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are routinely used to evaluate medical issues ranging from a tag football knee injury to blood clots in the kidneys. As useful as these techniques are, people with substantial kidney and renal artery problems are often excluded from their use because the iodinated and gadolinium-based contrast agents required can cause further damage or unwanted toxicity. Researchers have been seeking safe alternatives, such as manganese complexes. But the versions developed so far have not been stable enough to prevent displacement of manganese by other metals or able to meet other criteria such as quickly being eliminated from the body. Eric M. Gale, Peter Caravan, and colleagues at the A. A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital decided to sit down and design a new type of manganese chelating ligand that could provide a solution (J. Am. Chem. Soc. 2015, DOI: 10.1021/jacs.5b10748). The ligand, which they call PyC3A, creates a chelating environment highly resistant to manganese dissociation, can include functional groups for binding targeted tissues, and quickly clears from the body. The team synthesized PyC3A in five steps and reports that a fibrin-targeted derivative of the manganese contrast agent shown provides images of rat arterial blood clots comparable to the best gadolinium contrast agent without any apparent toxicity.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.